Telomir Pharmaceuticals Inc.

09/27/2024 | Press release | Distributed by Public on 09/27/2024 14:16

Material Agreement Form 8 K

Item 1.01 Entry into a Material Definitive Agreement.

On September 24, 2024, Telomir Pharmaceuticals, Inc. (the "Company") entered into an unsecured Promissory Note and Loan Agreement (the "Starwood Note") with The Starwood Trust ("Starwood"), a related-party trust established by the Company's founder.

The Company believes that the Starwood Note provides the Company with increased financial flexibility and the ability to access capital for operations on terms more favorable than terms currently available in the market. Further, the Company believes that the Starwood Note underscores the commitment and confidence from the Company's founding affiliates in the Company's future strategic direction and prospects. Importantly, the Starwood Note is structured as non-dilutive to the Company's outstanding common stock, thereby protecting current shareholder value. It allows the Company to pursue key initiatives without immediate financial pressure.

The Starwood Note contains the following material terms:

1. Under the Starwood Note, the Company may request loan advances of any amount on three (3) business days' notice ("Advances") from Starwood up to an aggregate amount of Five Million Dollars ($5,000,000). As of the date of this Current Report, no Advances have been requested by the Company. The Company currently anticipates that, given its cash on hand and planned operations, it will not need to request Advances until the first quarter of 2025, subject to the other financing opportunities which the Company may pursue.
2. The Starwood Note is not convertible into equity securities of the Company, and no common stock warrants were issued in connection with the Starwood Note.
3. The Starwood Note is unsecured and carries an interest rate of seven percent (7%) per annum on the principal amount of any Advances made, calculated as simple interest.
4. Any principal amount outstanding under the Starwood Note is payable on or before September 24, 2026.
5. The Company may prepay all or any portion of the Advances made under the Starwood Note at any time without penalty or premium.
6. The Starwood Note contains customary events of default and, upon an event of default, the outstanding principal amount under the Starwood Note will be become due and payable immediately at the election of Starwood. Further, upon occurrence of any event of default, Starwood, at its sole discretion, may deny Company's right to request Advances.

The Starwood Note was independently reviewed and approved by the Audit Committee (the "Audit Committee") of the Company's Board of Directors (the "Board") pursuant to the Company's Related Person Transaction Policy and Procedures, and with the recommendation of the Audit Committee, the full Board also approved the Starwood Note.

The above description of the Starwood Note is qualified in its entirety by the text of the Starwood Note, a copy of which is attached as Exhibit 10.1 to this Current Report on Form 8-K.